Curaleaf Holdings, Inc. (OTCMKTS:CURLF) Short Interest Down 6.6% in January

Curaleaf Holdings, Inc. (OTCMKTS:CURLFGet Free Report) was the recipient of a large drop in short interest in January. As of January 15th, there was short interest totalling 6,765,700 shares, a drop of 6.6% from the December 31st total of 7,246,500 shares. Based on an average daily trading volume, of 1,464,200 shares, the days-to-cover ratio is presently 4.6 days.

Analysts Set New Price Targets

A number of brokerages recently weighed in on CURLF. Roth Capital raised shares of Curaleaf to a “strong-buy” rating in a research note on Sunday, November 10th. Cormark downgraded shares of Curaleaf from a “moderate buy” rating to a “hold” rating in a report on Thursday, November 7th.

Check Out Our Latest Research Report on Curaleaf

Curaleaf Stock Down 7.0 %

CURLF stock traded down $0.10 during midday trading on Monday, hitting $1.32. The company’s stock had a trading volume of 827,439 shares, compared to its average volume of 598,575. The company has a quick ratio of 0.51, a current ratio of 1.11 and a debt-to-equity ratio of 0.85. Curaleaf has a 52-week low of $0.88 and a 52-week high of $6.40. The firm has a market capitalization of $866.04 million, a P/E ratio of -4.55 and a beta of 0.64. The firm has a 50-day simple moving average of $1.57 and a 200-day simple moving average of $2.53.

Curaleaf Company Profile

(Get Free Report)

Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.

See Also

Receive News & Ratings for Curaleaf Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Curaleaf and related companies with MarketBeat.com's FREE daily email newsletter.